An2 Therapeutics, Inc. · NASDAQ:ANTX

BML Investment Partners, L.P. reported a 10.70% stake in An2 Therapeutics, Inc. (Schedule 13D/A)

Event May 28, 2025 · Filed May 30, 2025

BML Investment Partners, L.P. reported a 10.70% stake in An2 Therapeutics, Inc., 3,217,423 shares, with active intent on May 28, 2025. Filed May 30, 2025 (Schedule 13D/A).

Stake
10.70%
Shares
3,217,423
Intent
Active
What changed
Stake changed

The filing in full

HolderStakeShares
BML Investment Partners, L.P.10.70%3,217,423

Source

View original at SEC

Related